Health

Refined Carbohydrate Intake Linked to MASLD

A prospective cohort study involving 12,134 Chinese adults examined the link between intake of refined carbohydrates, staple foods, and the risk of metabolic dysfunction-associated steatotic liver disease (MASLD). Over a median follow-up of 4.32 years, 4,447 new MASLD cases were identified. Higher total refined carbohydrate intake was associated with increased MASLD risk, with rice intake showing a particularly strong positive association. In contrast, wheat, coarse grains, and yams were linked to a lower risk. These associations were significant in women but not in men. Replacing one daily serving of rice with wheat or coarse grains was associated with reduced MASLD risk, and a dietary pattern characterized by low rice consumption was also protective. The findings highlight the importance of dietary choices, particularly staple food selection, in preventing MASLD among the Chinese population. Source: https://journals.lww.com/ajg/

hyangiu

Recent Posts

Early-Life Sugar Restriction Linked to Lower Risk of Early-Onset Cancer

Early-life sugar restriction during pregnancy and infancy was associated with a 34% lower risk of…

2 days ago

Domain-Specific Physical Activity and Dementia Risk

Higher levels of physical activity were associated with lower risks of all-cause dementia, Alzheimer’s disease,…

5 days ago

BMI and Waist Circumference Jointly Predict Mortality Risk in Older Adults

In US adults aged ≥65 years, overweight and class I–II obesity were associated with lower…

5 days ago

Longitudinal Heart Stress Status Predicts CVD and Mortality in Older Adults

In community-dwelling older adults without prior cardiovascular disease (CVD), new or persistent heart stress (HS)—defined…

6 days ago

The Obesity Paradox in Colorectal Cancer May Reflect Prediagnostic Weight Loss

In the German multicenter study of 5,521 patients with colorectal cancer (CRC), the apparent survival…

1 week ago

Stopping Statins for Primary Prevention After Age 75? Evidence from a Randomized Trial

In adults aged 75 years or older without a history of atherosclerotic cardiovascular disease (ASCVD)…

2 weeks ago

This website uses cookies.